Long-term Survival of Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma
Njei B. Long-term Survival of Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma. Journal Of Clinical Gastroenterology 2014, 48: 385-386. PMID: 24440939, PMCID: PMC4822547, DOI: 10.1097/mcg.0000000000000070.Peer-Reviewed Original ResearchConceptsHepatocellular carcinomaConventional hepatocellular carcinomaFibrolamellar hepatocellular carcinomaLong-term survivalPrognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Njei B, Konjeti VR, Ditah I. Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Gastrointestinal Cancer Research : GCR 2014, 7: 49-54. PMID: 24799971, PMCID: PMC4007676.Peer-Reviewed Original ResearchMean overall survivalOverall survivalFL-HCCHepatocellular carcinomaNoncirrhotic patientsSystematic reviewConventional HCCPrognosis of patientsConventional hepatocellular carcinomaFibrolamellar hepatocellular carcinomaRandom-effects modelOutcomes of interestSignificant increaseTypes of HCCLiver transplantationFibrolamellar variantHepatic resectionBetter prognosisClinical courseSurvival outcomesTherapeutic optionsCochrane LibrarySubgroup analysisEgger's testRevMan 5.1